Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Bouabdallaoui, N; Tardif, JC; Waters, DD; Pinto, FJ; Maggioni, AP; Diaz, R; Berry, C; Koenig, W; Lopez-Sendon, J; Gamra, H; Kiwan, GS; Blondeau, L; Orfanos, A; Ibrahim, R; Gregoire, JC; Dube, MP; Samuel, M; Morel, O; Lim, P; Bertrand, OF; Kouz, S; Guertin, MC; L'Allier, PL; Roubille, F

Tardif, JC (corresponding author), Montreal Heart Inst, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada.

EUROPEAN HEART JOURNAL, 2020; 41 (42): 4092

Abstract

Aims The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the benefits of targeting inflammation after myocardial infarction (MI). We ai......

Full Text Link